Abstract
Ca2+ regulates voltage-gated Na+ (NaV) channels and perturbed Ca2+ regulation of NaV function is associated with epilepsy syndromes, autism, and cardiac arrhythmias. Understanding the disease mechanisms, however, has been hindered by a lack of structural information and competing models for how Ca2+ affects NaV channel function. Here, we report the crystal structures of two ternary complexes of a human NaV cytosolic C-terminal domain (CTD), a fibroblast growth factor homologous factor, and Ca2+/calmodulin (Ca2+/CaM). These structures rule out direct binding of Ca2+ to the NaV CTD, and uncover new contacts between CaM and the NaV CTD. Probing these new contacts with biochemical and functional experiments allows us to propose a mechanism by which Ca2+ could regulate NaV channels. Further, our model provides hints towards understanding the molecular basis of the neurologic disorders and cardiac arrhythmias caused by NaV channel mutations.
Introduction
NaV channels underlie the rapid upstroke of action potentials. Mammalian NaV channels are pseudotetramers with 6-transmembrane segment repeats joined by intracellular linkers and flanked by intracellular N- and C-termini. The four repeats, which each contain a voltage sensor, assemble to form a central pore. Although recent crystal structures of the tetrameric bacterial NaV channel from Arcobacter butzleri (NavAb) provided detail about the pore and voltage sensors 1, 2, NavAb tetramers lack the intracellular linkers and termini of mammalian NaV channels. Those components are of particular interest because they confer isoform-specific regulatory effects, serve as sites of interaction for critical modulatory proteins, and are loci for many disease-causing mutations.
The C-terminal domain (CTD) is of particular interest because it exerts powerful effects upon channel inactivation 3 and is the interaction site for several auxiliary proteins that modulate channel function, such as calmodulin (CaM) and fibroblast growth factor homologous factors (FHFs), both of which regulate excitability through their CTD interactions 4, 5. Moreover, many disease-causing mutations localize to NaV CTDs or their associated proteins. Key examples include mutations in SCN1A and SCN2A (which encode the neuronal channels NaV1.1 and NaV1.2, respectively) that lead to various epilepsy syndromes, ataxia, and autism 6, 7, 8 or in the CTD of NaV1.5, the cardiac NaV channel encoded by SCN5A, which is a hotspot for mutations causing arrhythmias, cardiomyopathy, and sudden infant death syndrome 9, 10, 11, 12, 13, 14. Likewise, mutations in FHFs or CaM have been associated with neurodegenerative disorders, cognitive deficits, and arrhythmias 14, 15, 16. Structural information about NaV CTDs, however, has been limited. How the associated regulatory proteins influence channel function and how mutations in the CTDs or associated auxiliary proteins perturb channel function and at the molecular level are not well understood.
Among the proteins associated with NaV CTDs CaM is of particular interest because it acts as a sensor for Ca2+, which serves as a critical signal of electrical activity, providing powerful feedback regulation upon NaV channel function 17. Still, how Ca2+ and CaM affect NaV channels have been controversial since sequence analysis of NaV channels first revealed the presence of potential CaM-binding sites, including an “IQ” motif 5 and a potential Ca2+ binding site within the CTD 18. Obtaining an understanding for CaM regulation of NaV channels has been further complicated by apparent isoform-specific regulation. For example, CaM affects inactivation properties of the neuronal NaV1.6 but not the skeletal muscle NaV1.4 19. For the cardiac NaV1.5, CaM affects several different properties, including channel inactivation and persistent current 20, 21. Nevertheless, the identification of disease-causing mutations within or near the NaV IQ motifs of several NaV isoforms 6, 20, 22, 23, 24 highlights important roles for CaM. The potential significance of CaM-binding to NaV channels has been further spotlighted by recent exome sequencing studies in which searches for repeated rare variants or de novo mutations associated with autism identified SCN1A and SCN2A among the small list of loci 25, 26, 27; several of these cataloged NaV mutations cluster in and around the IQ motif.
A major barrier to understanding how Ca2+ and CaM act on NaV channels has been that structural information is limited to Ca2+-free CaM (apoCaM) interacting with the CTD. While such studies defined an interaction between the decalcified C-lobe of CaM and the IQ motif 28, 29, 30, those structures were unable to reveal how Ca2+ affects NaV function and did not provide insight into mechanisms for IQ motif disease mutations, including a familial autism mutation in the neuronal NaV1.2 channel 7 and a cardiac arrhythmia mutation in the cardiac NaV1.5 20 that fall outside of the apoCaM contact sites.
Here, we present crystal structures of NaV1.2 and NaV1.5 CTDs bound to Ca2+–CaM. Comparison with our previous structure obtained with apoCaM reveals novel and unexpected Ca2+–CaM contacts and stark differences in the overall conformation of the ternary complex, including a Ca2+-dependent interaction between the CaM N-lobe and an extended helix that contains the IQ motif. Together, these findings provide a basis for understanding the effects of specific disease-causing mutations within NaV CTD domains.
Results
Ternary complex structures of a NaV CTD, FHF, and Ca2+/CaM
To define how Ca2+ regulates NaV channels, we solved crystal structures of complexes containing a NaV CTD, Ca2+–CaM, and a FHF. FHFs are constitutive NaV subunits in brain 4, 31 and heart 32 and their inclusion allows us to compare Ca2+/CaM structures with our previous complex containing apoCaM 30. We tested several different combinations of FHFs and NaV CTDs with Ca2+/CaM and eventually succeeded in crystallizing two ternary complexes: a 6xHis-tagged human NaV1.5 CTD (amino acids 1773-1940), human FGF12B, and CaM; and a 6xHis-tagged human NaV1.2 CTD (amino acids 1777-1937), human FGF13U, and CaM. The sequences of the NaV CTDs are highly conserved among the subtypes (76% identities between NaV1.5 and NaV1.2, and 91% of the amino acids are conserved; Fig. 1a) and the solution structures of the proximal NaV1.2 CTD and NaV1.5 CTD are nearly identical 33, 34. Likewise, FGF12B and FGF13U are highly conserved (69% identities), and their crystal structures in the absence of any binding partners are similar 35. Thus, we anticipated significant similarities between the NaV1.2- and NaV1.5-containing complexes.
Both complexes were expressed in E. coli and purified in the presence of 2 mM Ca2+ by Co2+ affinity chromatography followed by size exclusion chromatography. The two ternary complexes (combined Mw ∼60 kDa) were stable and each eluted in a single peak on a size exclusion column (Supplementary Fig. 1). Their individual profiles were highly similar to each other and to what we observed for the ternary complex containing the NaV1.5 CTD, FGF13U, and CaM purified in EGTA, for which we had demonstrated a stoichiometry of 1:1:1 30.
The complex containing NaV1.2 CTD, FGF13U, and CaM (hereafter referred to as NaV1.2/Ca2+) was crystallized in the C2 space group with two copies of the ternary complex in each asymmetric unit. The crystals were grown in the presence of 2 mM Ca2+ and diffracted to 3.02 Å Bragg spacings. The experimental phases were derived by single anomalous dispersion from selenomethionine-substituted crystals and improved by two-fold non-crystallographic averaging, which yielded a good-quality electron density map (Supplementary Fig. 2a). The final model contains the NaV1.2 amino acids 1788-1929, FGF13U amino acids 11-158, and the CaM amino acids 7-149. The model was refined to Rwork/Rfree of 21.5/24.6 % (Table 1). The ternary complex containing NaV1.5 CTD, FGF12B, and CaM (hereafter referred to as NaV1.5/Ca2+) was crystallized in the P3121 space group with one copy of the ternary complex in each asymmetric unit. The crystals were grown in the presence of 2 mM Ca2+ and diffracted anisotropically to 3.8/5.4/6.0 Å Bragg spacings. Molecular replacement was performed to obtain the phases (see Methods for the details). The final model contains the NaV1.5 amino acids 1786-1927; FGF12B amino acids 12-152; and the CaM amino acid 7-148. Despite the resolution limit, the model refined to good statistics (Rwork/Rfree of 26.2/31.8 %) and good geometry (Table 1 and Methods for the refinement). 2Fo-Fc OMIT map shows a good-quality electron density, supporting the accuracy of the model given the resolution (Supplementary Fig. 2B). There is no significant difference in the refinement statistics when the data was truncated to 6.0 Å (Table 1).
Table 1.
Data collection | SeMet Nav1.2/CaM/FGF13/Ca2+ | Nav1.5/CaM/FGF12B/Ca2+ | Nav1.5/CaM/FGF12B/Ca2+ with 6 Å cutoff |
Space group | C2 | P3121 | P3121 |
Wavelength (Å) | 0.9792 | 1.0 | 1.0 |
Cell dimensions | |||
a, b, c (Å) | 153.13, 86.11, 109.40 | 115.199, 115.199, 120.107 | 115.199, 115.199, 120.107 |
α, β, γ (°) | 90.0, 100.9, 90.0 | 90.0, 90.0, 120.0 | 90.0, 90.0, 120.0 |
Resolution (Å) | 50.00 – 3.02 (3.07 – 3.02) | 50.00 – 3.80 (3.87 – 3.80)* | 50.00 – 6.00 (6.10 – 6.00) |
Rsym (%) | 16.4 (48.3) | 6.9 (39.2) | 5.7 (24.1) |
I/σI | 16.8 (1.5) | 34.7 (1.8) | 53.0 (7.6) |
Completeness (%) | 94.3 (66.6) | 46.1 (13.2) | 92.6 (61.5) |
Redundancy | 12.5 (5.6) | 7.2 (2.2) | 8.5 (6.5) |
SAD Phasing | |||
Figure of Merit | 0.30 (50.0 – 3.02 Å) | ||
Refinement | |||
Resolution (Å) | 48.23– 3.02 (3.09 – 3.02) | 41.75 – 3.84 (5.00 – 3.54)** | 41.75 – 6.00 (7.00 – 6.00) |
Completeness (%) | 91.8 (53.0) | 40.53 (12.91) | 92.89 (81.72) |
No. of reflections | 26179 | 3700 | 2301 |
Rwork/free | 21.48 / 24.64 | 26.01 / 31.75 | 23.61 / 31.82 |
Ramachandran (%) | |||
Favored | 95.7 | 95.5 | 95.5 |
Outliers | 0.4 | 0.5 | 0.5 |
R.m.s.d | |||
Bond lengths (Å) | 0.011 | 0.011 | 0.012 |
Bond angles (°) | 1.04 | 0.996 | 1.093 |
Rsym = Σ | Ii - < Ii > | / Σ Ii, where < Ii > is the average intensity of symmetry-equivalent reflections. Rwork = Σ | Fo – Fc | / Σ | Fo |, where Fo and Fc are the observed and calculated structure factors, respectively. Rfree = R-factor calculated using a subset (5-8%) of reflection data chosen randomly and omitted throughout refinement. The figure of merit = |F(hkl)best|/|F(hkl)| and calculated using Phaser before density modification.
The crystal diffracts anisotropically to 3.8/5.4/6.0 Å.
The data treated with ellipsoidal truncation and anisotropic scaling was used for refinement(1).
Figure 1B-C show the overall architecture of the NaV1.2/Ca2+ and NaV1.5/Ca2+ ternary complexes, respectively. In both complexes, the NaV CTD is comprised of one globular domain that contains an EF-hand fold followed by an extended helix that contains the IQ motif. We refer to this helix as the IQ domain. The FHF binds to the CTD globular domain and CaM binds to the IQ domain. When the NaV1.5/Ca2+ and the NaV1.2/Ca2+ structures were superimposed with respect to their IQ domain, structural conservation was observed within the region containing the IQ domain and CaM (r.m.s.d. of 1.7 Å) (Fig. 1D).
When the two structures (stripped of their respective CaM molecules) are superimposed relative to their respective CTD's globular domains together with FHFs, both NaV CTD globular domains and FHFs are very similar with the r.m.s.d of 0.89 Å, with their IQ domains out of register (Fig. 1E) due to different angles between their CTD's globular domain (along with FHFs) and their IQ domain. The different angle may reflect an isoform-specific structural difference or inherent flexibility between the two domains of NaV CTD.
To focus on the Ca2+ dependent conformational changes, we also superimposed our previously solved structure of a ternary complex of NaV1.5 CTD, FGF13, and CaM crystalized in the absence of Ca2+ 30, hereafter referred to as NaV1.5/-Ca2+. With the CaM molecules stripped for clarity, Fig. 1E shows that the difference in angle between the respective NaV CTD globular domains and the IQ domains is even more pronounced between NaV1.5/Ca2+ and NaV1.5/-Ca2+ than between NaV1.2/Ca2+ and NaV1.5/Ca2+ (Fig. 1E). Although it is possible that these rigid-body motions between the CTD globular domains and their respective IQ domains are associated with Ca2+ binding, these motions can also be due to inherent flexibility between these two domains. Because the NaV1.2/Ca2+ structure provides higher resolution than the NaV1.5/Ca2+ structure and the differences are otherwise minimal, subsequent analyses focus only on the NaV1.2/Ca2+ structure.
A Ca2+-dependent CaM N-lobe interaction with the IQ domain
The most significant effects of Ca2+ are the changes in the interactions between CaM and the respective IQ domains as shown in Figure 2A, B, in which the NaV1.2/Ca2+ and NaV1.5/-Ca2+ structures are aligned by their IQ domains. The CaM in the NaV1.5/-Ca2+ structure adopts an extended conformation with the α-helical interlobular linker between the CaM/N- and C-lobes holding the N-lobe away from the C-lobe that binds to the proximal portion (IQ motif) of the IQ domain. NMR structures of Ca2+-free CaM and an isolated IQ domain peptide from either NaV1.2 or NaV1.5 also showed an interaction between the CaM C-lobe and the IQ motif, but not the CaM N/lobe and the IQ domain 28, 29. In our new NaV1.2/Ca2+ structure, in contrast, the α-helical interlobular linker is unwound, thereby allowing the Ca2+-bound CaM N-lobe to envelope the distal portion of the IQ domain and provide additional contacts between the linker and the IQ domain and between the CaM N-lobe and the IQ domain that are not present in the absence of Ca2+. These new contacts include residues mutated in channelopathies, as discussed below.
Superposition of NaV1.5/-Ca2+ and NaV1.2/Ca2+ structures shows that there are only minor conformational changes with respect to CaM C-lobe. In both structures, the CaM C-lobe adopts the “semi-open” conformation (Fig. 2C) that was first described for apoCaM bound to an IQ motif from an unconventional myosin 36. Significant conformational changes, however, occurred within the N-lobe of CaM, which assumes a “closed” conformation in the NaV1.2/Ca2+ structure (Fig. 2C and 2D), similar to the conformation observed for the N-lobe of Ca2+/CaM bound to its target peptide in CaMKII 37. For comparison, in the NaV1.5/-Ca2+ structure the unbound CaM N-lobe displays the “semi-open” conformation 30. Additionally, the arrangement of CaM lobes with respect to the IQ domain is novel to the best of our knowledge (see Discussion for the further details).
These conformation differences of the individual CaM lobes in the NaV1.2/Ca2+ structure suggested that the C-lobe was unlikely to be fully occupied while the N-lobe is saturated with Ca2+. To test this hypothesis we collected data for the NaV1.2/Ca2+ crystals at a long wavelength (1.55 Å), for which the anomalous scattering power of Ca2+ (f″ ∼1.2 e) is higher than that of sulfur (∼0.6 e) while that of Mg2+ is nearly silent (∼0.1 e). Although we observed strong anomalous difference Fourier peaks in the Ca2+-binding loops of the CaM N-lobes, only weak peaks were observed in the Ca2+-binding loops of the CaM C-lobe (Supplementary Fig. 3), suggesting that the affinity for Ca2+ in the CaM C-lobe of NaV1.2/Ca2+ is low (compared to the CaM N-lobe) and that the CaM C-lobe is only partially occupied with Ca2+, consistent with the semi-open conformation of the CaM C-lobe.
This newly discovered interaction between the CaM N-lobe and the distal C-terminal portion of the IQ domain is driven mainly through van der Waals forces (Fig. 2E), burying NaV1.2 hydrophobic side chains (Leu1920, Leu1921, Val1925, and Val1928) and has functional and disease-related implications. First, this additional interaction between the distal IQ domain and the CaM N-lobe offers an explanation for a previous report that an Ala1924Thr mutation in the cardiac NaV1.5 channel (equivalent to Val1928 in NaV1.2) causes the life-threatening arrhythmia Brugada Syndrome and eliminates the Ca2+/CaM-dependent slow inactivation observed for the wild-type NaV1.5 channel 20. We hypothesized that the Ala1924Thr mutation in the NaV1.5 CTD affected the affinity for Ca2+/CaM, and tested the hypothesis by isothermal calorimetry (ITC). Indeed, in the presence of saturating 5 mM Ca2+, the mutation reduced the affinity for Ca2+/CaM by ∼ 3-fold compared to the wild-type NaV1.5 CTD (Supplementary Fig. 4A and Table 2). In contrast, the affinity of the mutant NaV1.5 CTD for CaM in the absence of Ca2+ was mildly increased (Table 2). Second, we found that the CaM N-lobe interaction with the distal IQ domain provides a significant boost to the affinity of Ca2+/CaM for the NaV CTD. A previous report using ITC 38 had found the affinity of Ca2+/CaM for a NaV1.5 peptide containing the IQ motif to be ∼ 2.1 μM. Those thermodynamic parameters, however, were obtained in experiments employing an IQ domain in which the newly discovered CaM N-lobe contact site is truncated. We therefore performed ITC with a longer NaV1.5 CTD (through amino acid 1940), and observed a significantly higher affinity for both Ca2+/CaM and apoCaM (∼100 nM, as shown in Supplementary Fig. 4A-B and Table 2). To assure that the lower Kd values we obtained were indeed due to the longer CTD and not to technical differences, we measured the affinity of CaM for the NaV1.5 CTD truncated at amino acid 1924, for which we obtained a value of 2.0 ± 0.4 μM in 5 mM Ca2+ (Table 2 and Supplementary Fig. 4B). This result is in excellent agreement with the value previously obtained 38, thereby allowing us to benchmark our thermodynamic data against that report. Thus, the ∼ 20-fold higher affinity for CaM obtained with the longer CTD highlights critical contributions of the more distal IQ domain residues. Comparison of the N values of interactions for Ca2+/CaM with the two CTDs by ITC (Table 2) further demonstrates the importance of the more distal residues in the IQ domain. For the shorter CTD, the N value of the Ca2+/CaM-CTD interaction is close to ∼0.5 (0.38 in our measurement; and 0.56 previously reported 38), suggesting that one Ca2+/CaM can bind two CTDs. The N value we obtained for the longer CTD was doubled (0.84), suggesting that one Ca2+/CaM binds one CTD, and fits well with our crystallographic observation that both N- and C-lobes simultaneously bind to different sites within the IQ domain of NaV CTD. Consistent with our observation, N value of the interaction between Ca2+/CaM and Ala1924Thr of the longer CTD is reduced to half of the wild type (0.42) (Table 2). Thus, these data underlined the importance of the interaction between CaM and the more distal region of the IQ domain and supported a model in which there are simultaneous interactions of the two CaM lobes (at different sites on the IQ domain).
Table 2. Thermodynamic parameters for CaM interaction with the NaV1.5 CTD.
Titrant | N | Cell | Kd (nM) | ΔH (kcal/mol) | ΔS(cal·mol-1· deg-1) | N value |
---|---|---|---|---|---|---|
Ca2+/CaM | 3 | 1773-1924 | 1990 ± 358 * | -3.77 ± 0.27 | 12.4 ± 0.5 | 0.38 ± 0.02 |
apoCaM | 4 | 1773-1940 | 88 ± 6 * | -10.69 ± 0.06 | -4.2 ± 0.3 | 0.94 ± 0.03 |
Ca2+/CaM | 3 | 1773-1940 | 132 ± 9 | -9.94 ± 0.33 | -2.4 ± 0.1 | 0.83 ± 0.05 |
Ca2+/CaM | 3 | 1773-1940 (A1924T) | 497 ± 32 * | -7.81 ± 0.09 | 2.1 ± 0.2 | 0.42 ± 0.02 |
apoCaM | 3 | 1773-1940 (A1924T) | 61 ± 4 * | -11.16 ± 0.14 | -5.1 ± 0.3 | 0.70 ± 0.01 |
P < 0.05 compared to NaV1.5 CTD (amino acids 1773-1940) plus Ca2+/CaM
Ca2+-dependent changes and disease mechanisms
While the new CaM N-lobe contact with the NaV1.2 CTD is the most obvious Ca2+-dependent structural change, we also identified additional new Ca2+/CaM contact sites within the NaV1.2 IQ domain, which may provide insight for several other NaV channelopathies. For example, Arg1918 (Fig. 3A, B), which contacts Asp79 and Ser82 in the CaM interlobular linker in the Ca2+-loaded complex (but not in the apoCaM structure), was reported in a patient with febrile seizures and childhood absence epilepsy 23, and mutation of the equivalent Arg1928 in the homologous NaV1.1 was found in a patient with severe myoclonic epilepsy of infancy 24.
Also of particular interest was a familial autism mutation Arg1902Cys in NaV1.2 7, particularly since recent analyses of rare de novo mutations in subjects with autism have identified SCN2A as one of a handful of high-confidence autism spectrum disorder genes 25, 39. Arg1902 sits at the hinge between the CTD globular domain and the IQ domain helix (Fig. 3C). We had previously found that the Arg1902Cys mutation conferred a Ca2+/CaM-dependent conformational change indicated by a significant Ca2+-dependent shift in migration on a size exclusion column of a NaV1.2 CTD/CaM binary complex that was not observed with the wild type complex 21. Although Arg1902 (or the Arg1898 equivalent in NaV1.5) does not make any direct contacts with CaM either in the presence or absence of Ca2+, it interacts with the side chain of Glu1905 (Glu1901 in NaV1.5) one turn below along the IQ domain helix and also forms cation-π interaction with the side chain of Tyr98 in FGF13 in the NaV1.5/-Ca2+ structure. Tyr98 in FGF13 and Glu1905 in NaV1.2 (Glu1901 in NaV1.5) also interact with Lys95 within the third CaM EF-hand in the CaM C-lobe. Interestingly, Glu1905 in NaV1.2, Tyr98 in FGF13, and Lys95 in CaM are the only residues within the ternary complex that make interactions with each of the other partners. Thus, we suspected that the relayed interactions from Lys95 (CaM) through Glu1905 (Nav IQ domain) to Arg1902 (Nav globular domain), stabilized by the cation-π interaction with Tyr98 in FGF13, suppress the Ca2+ dependence of NaV1.2 channels and that disruption of these interactions would affect Ca2+-dependent regulation of NaV1.2 channels (Fig. 3C). We tested this hypothesis in two ways.
First, we expressed either wild type or Arg1902Cys mutant NaV1.2 along with FGF14, the best characterized neuronal FHF 4, 31, 40 in HEK293 cells, in which endogenous CaM is abundant, and recorded Na+ currents in the presence of saturating internal Ca2+ or nominally zero internal Ca2+ (Supplementary Fig. 5) For wild type NaV1.2, inclusion of 10 μM Ca2+ in the patch pipette did not affect peak current density, the V1/2 of activation, or the V1/2 of steady-state inactivation. In contrast, for the Arg1902Cys mutant the addition of Ca2+ induced a large ∼-10 mV shift in the V1/2 of steady-state activation and inactivation (Fig. 3D, Supplementary Fig. 6A, and Supplementary Table 1). To test further our hypothesis that disruption of the NaV CTD to CaM relay affected Ca2+-dependent regulation of NaV1.2, we ablated the key intermediary by mutating NaV1.2 Glu1905 to Gln. Recordings from the Glu1905Gln mutant channels phenocopied those from the Arg1902Cys mutant channels (Supplementary Fig. 6A and Supplementary Table 1). Second, to test the proposed role of Arg1902 in the relayed interactions in NaV1.2 CTD/apoCaM, we measured the affinity of apoCaM for the wild type and Arg1902Cys mutant NaV1.2 CTDs by ITC. Consistent with our hypothesis, the Arg1902Cys mutation reduced affinity of apoCaM for the NaV1.2 CTD significantly (Table 3 and Supplementary Fig. 4C). We did not observe a difference in affinity for Ca2+/CaM between the wild type and the Arg1902Cys mutant CTD (Table 3 and Supplementary Fig. 4D). Because our ITC measurement in the presence of Ca2+ could be complicated by an additional binding process due to Ca2+-loading of the CaM C-lobe, which is essentially unoccupied in the NaV1.2/+Ca2+ structure (Supplementary Fig. 3), we therefore prepared CaM in which the third and fourth EF hands were mutated to ablate Ca2+ binding to the CaM C-lobe 41 and repeated the ITC measurements with this crippled CaM34 mutant. The ITC experiment with the CaM34 mutant showed a reduced affinity for the Arg1902Cys mutant compared to the wild CTD in the presence of Ca2+ (Table 3 and Supplementary Fig. 4E). Thus these data are consistent with the previously observed shift in mobility on gel filtration of the Arg1902Cys/CaM binary complex 21 and suggest that by disrupting the relayed interactions to CaM the familial autism NaV1.2 Arg1902Cys mutation revealed Ca2+-dependent effects upon channel function that were suppressed in the wild type channel.
Table 3. Thermodynamic parameters for CaM interaction with the NaV1.2 CTD.
Titrant | N | Cell | Kd (nM) | ΔH (kcal/mol) | ΔS (cal·mol-1·deg-1) | N value |
---|---|---|---|---|---|---|
apoCaM | 3 | WT | 36 ± 6 | -4.54 ± 0.1 | 18.6 ± 0.2 | 1.02 ± 0.02 |
Ca2+/CaM | 3 | WT | 1713 ± 333 | 6.01 ± 0.5 | 47.0 ± 1.3 | 0.76 ± 0.02 |
Ca2+/CaM34 | 3 | WT | 388 ± 22 | -13.85 ± 0.4 | -17.9 ± 1.4 | 0.86 ± 0.05 |
apoCaM | 3 | R1902C | 958 ± 80 * | -3.28 ± 0.3 | -2.1 ± 0.2 | 0.58 ± 0.13 |
Ca2+/CaM | 3 | R1902C | 1510 ± 187 | 6.19 ± 0.9 | 48.0 ± 2.8 | 0.74 ± 0.03 |
Ca2+/CaM34 | 3 | R1902C | 2931 ± 123 * | -12.53 ± 0.9 | 17.4 ± 2.8 | 0.49 ± 0.02 |
P < 0.05 compared to WT.
We next investigated whether the Ca2+-dependent interaction of the CaM N lobe was required for the Ca2+-dependent regulation of NaV1.2 exposed by the Arg1902Cys mutation. We mutated Val1925, one of the NaV1.2 hydrophobic side chains buried by the calcified CaM N lobe (see Fig. 2E), to Lys and examined how this mutant affected the Ca2+-dependent shift in activation and steady-state inactivation in the context of the Arg1902Cys mutant. With this additional Val1925Lys mutation, The Arg1902Cys mutant no longer displayed any Ca2+-dependent effects on either activation or steady-state inactivation (Supplementary Fig. 6B and Supplementary Table 1), thereby implicating a requirement for the interaction between the calcified CaM N lobe and NaV1.2. When analyzed independently, Val1925Lys did not expose any Ca2+-dependent regulation (Supplementary Fig. 6B and Supplementary Table 1).
Ca2+ binding is restricted to calmodulin
Our analyses suggested that Ca2+-dependent regulation of NaV channel function derives from Ca2+-dependent changes in the interaction between CaM and the NaV CTD, yet it has previously been suggested that Ca2+ also affects NaV channels by binding directly to an EF-hand motif within the NaV CTD influences NaV channel function 18, 34, 42. To query whether Ca2+ can bind directly to the NaV CTD EF-hand motif, we used our anomalous scattering studies. Even though we detected anomalous difference signals from many sulfur atoms (in methionines) whose signal is ∼2-fold weaker than that for Ca2+, we did not detect anomalous difference signal for Ca2+ within the proposed Ca2+-binding loops (Fig. 4A) and we observed a strong signal for Ca2+ bound to the CaM N-lobe (Supplementary Fig. 3). Comparing the acidic and polar residues proposed to coordinate Ca2+ in the putative NaV CTD EF-hand 18 with those in the Ca2+-binding EF hands in the CaM N-lobe of the associated CaM provides an explanation. While both EF hands of the Ca2+-loaded CaM N-lobe contain a sufficient number of acidic and polar residues (a total of five) positioned to coordinate Ca2+ in an optimal geometry (Fig. 4B and see Fig. 2D), the NaV CTD EF hand does not (Fig. 4B). Thus, we conclude that the NaV CTD EF hand does not likely bind Ca2+; Ca2+-dependent effects on NaV channel function are more likely mediated via CaM.
Discussion
Whether and how Ca2+ contributes to the regulation of voltage-gated NaV currents has been a focus of significant controversy since potential CaM binding sites were first identified within NaV CTDs 5. Our new structural model with Ca2+/CaM bound to the NaV1.2 CTD, in context with previous structures demonstrating the interaction of apoCaM with various NaV CTDs 28, 29, 30, reveals novel and unexpected interactions between the Ca2+-loaded CaM and the NaV CTD. The apoCaM structures showed that the CaM C-lobe is anchored to the signature IQ motif within the extended IQ domain. On the basis of our new structural, biochemical, and functional data we propose that a major action of Ca2+ is to induce a conformational switch in the anchored CaM so that the CaM N-lobe swings into contact with the distal IQ domain while the Ca2+-free CaM C-lobe remains anchored to the IQ motif (Fig. 2b). Interestingly, the new contact site for the calcified CaM N-lobe sits within a previously identified peptide that, when isolated from the adjacent IQ motif peptide, could only bind Ca2+-loaded CaM, in contrast to the IQ motif that supported apoCaM binding over Ca2+/CaM binding 5. Additionally, we observed that Ca2+ induces rearrangements between the NaV CTD and the CaM intralobular linker, and between the NaV CTD and the CaM C-lobe (Fig. 3). We hypothesize that, together, these conformational changes may be propagated to the adjacent DIV transmembrane region of the channel to thereby affect NaV function in an isoform-specific manner. Since our structures do not contain the transmembrane region of the channel, our model cannot explain how the conformational changes propagate to DIV. However, it is known that the conformational change of DIV voltage sensor (S4) is the rate-limiting step for channel inactivation 43, 44. Thus, the NaV CTD is in an advantageous position to affect channel gating.
Interestingly, the specific Ca2+/CaM-dependent effects appear to vary among different NaV channels 19. Our data add to that concept in that we found that the wild type NaV1.2 channel, not previously studied, was insensitive to Ca2+/CaM for the parameters we studied at either nominally zero or saturating (∼ 10 μM) intracellular Ca2+. While the specific concentrations of internal Ca2+ studied here are outside the range of physiologic Ca2+ in neurons, these two levels allowed us to explore the bounds of Ca2+, and correlate to our structures, obtained in the absence or presence of Ca2+. These studies were also performed in the presence of a FHF, which was a component of the crystalized ternary complexes. Whether FHFs influence the Ca2+-dependence of NaV currents has not yet been analyzed. However, their inclusion in the functional studies is appropriate not only because of their presence in the crystal structures, but also because of growing evidence that FHFs are important regulators of NaV currents in the neurons and cardiomyocytes 4, 16, 32, 45 in which NaV1.2 and NaV1.5 are expressed.
Nevertheless, the familial autism mutation Arg1902Cys introduced a large Ca2+-dependent shift in both channel activation and steady-state inactivation (Fig. 3 and discussed below). A gain-of-function effect of a channelopathic mutation is reminiscent to the mechanism by which mutations in NaV1.5 lead to Long QT Syndrome 9, 10 and in some NaV1.2 mutations associated with epilepsy 46. Combined with analysis of the NaV1.2/Ca2+ structure, our functional data suggests that the relayed interactions from Lys95 (CaM) through Glu1905 (Nav IQ domain) to Arg1902 (Nav globular domain) mask a Ca2+-dependent shift in wild type NaV1.2 that is revealed by the Arg1902Cys familial autism mutant when the relay is disrupted. It is noteworthy that an Asp96Val mutation adjacent to Lys95 in CaM, recently reported in a patient with an arrhythmia syndrome, was also associated with moderate cognitive impairment 14.
Taken together, we suggest that similar Ca2+-induced conformational changes of CaM in both NaV1.2 and NaV1.5 (interactions of the CaM N-lobe to the distal IQ domain of NaV CTD) might be responsible for Ca2+-dependent regulation, and that their functional effects are isoform-specific. The concept that Ca2+-dependent regulation may be isoform-specific is consistent with a recent report showing that a rapid increase in intracellular Ca2+ diminished transient NaV currents through NaV1.4, but not through the NaV1.5 isoform 47. With regard to NaV1.2, only Arg1902Cys or Glu1905Gln unveiled a Ca2+-dependent functional effect. We reasoned that there are possible reasons for these isoform-specific differences of Ca2+ dependence. First, in the context of the full-length channels, it is possible that the conformational changes at the CTD could propagate to the DIV transmembrane region of the channel differently depending on the isoforms. The apparent isoform-specific difference in the angle between the NaV globular domain and the extended IQ domain reported herein (Fig. 1e) provide one possibility. For example, perhaps the difference in the angle within NaV1.2 masks the Ca2+-dependent changes in NaV1.2 wild-type channel function initiated by the Ca2+-dependent CaM N-lobe interaction. Second, it is possible that there are unexamined functional parameters that are more relevant to Ca2+-dependent regulations that are less-isoform specific. Third, it is possible that Ca2+/CaM does not mediate the observed Ca2+-dependent changes in functions of NaV1.2 Arg1902Cys or Glu1905Gln. However, the fact that Val1925Lys mutation (in the background of Arg1902Cys) abolishes the Ca2+-dependent functional effect eliminates this possibility, as Val1925Lys would disrupt the binding of the CaM N-lobe to the distal IQ motif of NaV1.2.
While mutagenesis studies have yielded suggestions about how Ca2+/CaM regulates NaV channel function 18, 19, 21, 38, 42, 48, 49, human disease mutations can be particularly revealing. By identifying new Ca2+/CaM-dependent contacts with the NaV CTD and demonstrating Ca2+-dependent conformation changes within the complex, our data provide a context in which to consider the effects of disease mutations that affect NaV CTD-CaM interaction. Several epilepsy mutations in NaV1.1 or NaV1.2 are in residues that make different contacts with Ca2+/CaM compared to apoCaM (Fig. 3) as are additional NaV1.1 and NaV1.2 mutations associated with sporadic and familial cases of autism 7, 25, 26. Further, our analysis of the effects of the NaV1.2 Arg1902Cys familial autism mutation demonstrates that disruption of the wild type interaction between the CaM C-lobe and the CTD induces a Ca2+-dependent change for the mutant NaV1.2 channel function. The marked hyperpolarizing shift in both NaV1.2 activation and inactivation induced by the Arg1902Cys autism mutation would affect neuronal excitability in NaV1.2 expressing neurons, thus leading to an imbalance between excitation and inhibition known to drive neuropsychiatric phenotypes 50. Additionally, our identification of the Ca2+-dependent CaM N-lobe interaction with the distal IQ domain, not predicted by previous structural studies, provides a molecular mechanism for the Ca2+-dependent dysfunction of the NaV1.5 Ala1924Thr Brugada Syndrome mutation 20. Finally, our data provide a potential mechanism for the recently described mutations in CaM associated with arrhythmias and cognitive deficits 14.
The Ca2+-loaded ternary complexes present several unusual and novel features for a CaM-containing complex. Among these are the dissimilar conformations of the CaM N-lobe and CaM C-lobe when calcified CaM is bound to the IQ domain (Fig. 2C). While the different conformations of the individual CaM lobes in our structures mirror the CaM lobe conformations seen in the SK K+ channel structure, the interactions between CaM and its target peptide(s) are markedly different. Within the SK K+ channel homotetramer, the calcified CaM N-lobe wraps around one helix from the C-terminus of a protomer but the apoCaM C-lobe interacts with two helices from a different protomer within the tetramer 51. Split roles for CaM lobes have also been suggested for Ca2+-dependent regulation of CaV channels 52, 53, 54, with one lobe responsible for mediating changes to global Ca2+ while the other responds to changes in local Ca2+. Comparison of our structures with CaV Ca2+ channel-derived structure provides an interesting contrast in structure and mechanisms by which Ca2+ regulates ion channel function, particularly since voltage-gated Na+ channels and Ca2+ channels are similar in sequence within their proximal CTDs. The similarities include not only the IQ domain to which CaM binds but also an EF hand motif in the CaV1.2 L-type Ca2+ channel that was hypothesized to serve as a site for Ca2+-dependent regulation 55, but (similar to the EF-hand in the NaV CTD) has also never been shown to bind Ca2+ with a physiologically meaningful affinity. In spite of these similarities in sequence, structures of the CaV CTDs bound to CaM are surprisingly different from what we observe for the NaV CTDs. Foremost among these differences is that the CaV CTD/CaM complexes crystallized as a dimer of CTDs, and each CTD interacted with two CaM molecules for an overall stoichiometry of 4 CaM and 2 CTDs 56, 57. Whether the dimerization of channels observed in the structure is functionally relevant has been debated. Nevertheless, the 2:1 stoichiometry between CaM and the CaV1.2 CTD contrasts markedly with the 1:1 stoichiometry between CaM and a NaV CTD. With these differences, it is not surprising that the overall fold of the CaV1.2 CTD does not resemble the NaV CTDs.
Even focusing specifically on the interactions between Ca2+/CaM and the respective IQ domains, the structures reveal stark differences (Fig. 5A-C). First, the arrangement of CaM with respect to the NaV IQ domain is very different than CaV IQ domains. In both CaV1.2 and CaV2.1 IQ domains, CaM wraps around the IQ motif in a right-handed helical fashion, regardless of the relative orientation of the IQ motifs (parallel or antiparallel to CaM lobes). On the contrary, CaM wraps around the NaV IQ domain in a left-handed helical fashion. Second, the overall Ca2+/CaM footprint on the NaV IQ domain is longer. The signature IQ motif in CaV channels forms a central anchor for Ca2+/CaM interactions with both CaM lobes, while the IQ motif residues in the NaV structures form contacts mostly with the CaM's Ca2+-free C-lobe. Thus, the Ca2+/CaM N-lobe is located further towards the C-terminus on the NaV IQ domains compared to the CaV IQ domains. A search of the Dali database 58 suggesting that the CaM conformation in the NaV1.2/Ca2+ and NaV1.5/Ca2+ structures is novel.
Together with this novel interaction mode between CaM and the NaV1.2 CTDs, our structural, biochemical, and functional data provide a new framework for understanding how CaM affects NaV channels in physiology and disease.
Methods
Molecular biology
The following plasmids, for protein expression and purification, have been previously described: For crystallization the human NaV1.5 CTD (amino acids 1773-1940) and NaV1.2 (amino acids 1777-1937) were cloned into pET28 (Novagen) 21; the human FGF13U (accession # NM_033642) and FGF12B were cloned into the second multiple cloning site of pETDuet-1 (Novagen) 59; and CaM was cloned into pSGC02 21. For isothermal titration calorimetry, human NaV1.5 CTD amino acids 1773-1924, NaV1.5 CTD amino acids 1773-1940 (and the Ala1924Thr mutant) were cloned into pET28. For electrophysiology, NaV1.2 was in pcDNA3.1 and FGF14b has previously been described 60. Site-directed mutagenesis was performed with QuikChange (Stratagene).
Recombinant protein expression and co-purification
The three plasmids for His6-Nav1.5 CTD, FGF12B, and CaM or His6-Nav1.2 CTD, FGF13U and CaM were co-electroporated into BL-21 (DE3) cells. Proteins were grown in LB medium or M9 medium as described 30. Cells were harvested and resuspended in 300 mM NaCl, 20 mM Tris-HCl, 5 mM imidazole, 2 mM CaCl2, pH 7.5, supplemented with EDTA-free protease inhibitor mixture (Roche). The initial purification protocol has been previously described 30. Additional purification was performed by gel filtration on a Superdex 200 10/300L column on an AKTA FPLC (GE Healthcare) in 300 mM NaCl, 20mM Tris-HCl, 5 mM imidazole, with 2 mM CaCl2, pH 7.5. Protein concentrations were determined by UV absorbance with Thermo NANODROP and were concentrated to A280 = 12 in above buffer for crystallization. For ITC experiments, the single plasmid was electroporated into BL-21 (DE3) cells and the proteins were expressed after induction with 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 16h at 20°C. CaM protein was purified as previously described 41.
Crystallization, data collection and structure determination
Crystals were grown by vapor diffusion with the sitting-drop method. His6-Nav1.5 CTD, FGF12B, and Ca2+/CaM crystals were obtained with 20% PEG3350, 0.18 M MgSO4, 0.1 M sodium iodide, and 2 mM CaCl2. His6-Nav1.2 CTD, FGF13U, and CaM selenomethionine incorporated proteins crystals were obtained with 14% pEG3350, 300 mM sodium acetate, 50 mM Tris pH 7.5, and 2 mM CaCl2. Before flash-freezing in liquid nitrogen, the crystals were cryoprotected by gradually increasing the concentration of glycerol in the well solution to 20%.
Crystals of selenomethionine (SeMet)-substituted NaV1.2 in complex with Ca2+/CaM and FGF13 diffract to 3.02 Å Bragg spacings with the space group C2 and crystals of human NaV1.5 CTD in complex with Ca2+/CaM and FGF12B diffract to 3.8 Å /5.4 Å /6 Å with the space group P3121 (Table 1). As for the structure determination of the complex of NaV1.2 CTD, Ca2+-CaM, and FGF13U, experimental phases were obtained from the SeMet-substituted complex using single anomalous dispersion (SAD). After initial automatic model building, model building was completed manually. The final model contains two complexes in the asymmetric unit and is refined to R/Rfree of 21.5/24.6% with good geometry (Table 1). The model contains residues 1788 to 1929 of Nav1.2. As for the structure determination of the complex of NaV1.5, Ca2+-CaM, and FGF12B, molecular replacement was performed to obtain the phases. In brief, the EF hand domain (residue 1786-1896) together with FGF13 from the previous Nav1.5 CTD structure in complex with FGF13U structure and Mg2+-CaM (PDB ID:4DCK), IQ domain (residue 1899-1919) from the same complex structure, and the C-lobe of Mg2+-CaM (residue 85-145) were used as independent search models and used to find the solutions using Phaser 61. After the solution was found, the N-lobe of CaM was manually placed using Fo-Fc map. Low-resolution structure refinement was performed using the reference model as the complex of Nav1.2, Ca2+/CaM and FGF13. The serious anisotropy of amplitudes were corrected using the UCLA Diffraction Anisotropy Server (http://services.mbi.ucla.edu/anisoscale) 62 and was used for the refinement. The final model contains one complex in the asymmetric unit and is of good quality with R/Rfree of 26.0/31.8% (Table 1).
Isothermal Titration Calorimetry
Experiments were performed with an ITC-200 (MicroCal) at 20 °C. The solutions containing the wild type NaV1.5 CTD, NaV1.2 CTD , NaV1.2 CTD R1902C mutation, NaV1.5 CTD amino acids 1773-1924, truncation mutant, or A1924T mutant (25-35 μM) were titrated with 1 injection of 5 μl and 27 injections of 10 μl of solutions containing CaM or CaM34 (240-310 μM). ITC experiments were repeated with different preparations and different concentrations at least three times to confirm thermodynamic parameters and stoichiometry values. The binding isotherms were analyzed with a single site binding model using the Microcal Origin version 7.0 software package (Originlab Corporation), yielding binding enthalpy (ΔH), stoichiometry (n), entropy (ΔS), and association constant (Ka). Results are presented as mean ± standard error; statistical significance was assessed using a two-tailed Student's t-test and was set at P < 0.05.
Electrophysiology
Human embryonic kidney (HEK) 293T cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS). The cells were plated on 60-mm tissue culture dishes and grown to 65%–75% confluence, then transfected using Lipofectamine 2000 (Invitrogen) with a total 6 μg of cDNAs encoding NaV1.2, FGF14b, β1, and β2 at a ratio of 2:1:1. One day after transfection, the cells were re-plated on coverslips coated with 50 μg/ml poly-D-lysine (Sigma) for electrophysiological recordings. Transfected cells were identified by GFP fluorescence. Na+ currents were recorded using the whole-cell patch-clamp technique at room temperature (20-22 °C) 48-72 h after transfection. Electrode resistance ranged from 2.5-2.5 MΩ. Currents were filtered at 2.9 kHz and digitized at 20 Hz using an EPC 10 USB patch amplifier (HEKA Elektronik). Cells were allowed to stabilize for 7-10 min after the whole-cell configuration was established. Cells expressing peak currents amplitude >6000 pA were excluded from kinetic analyses because of suboptimal voltage control, as were cells exhibiting peak current amplitudes <600 pA to avoid contamination by endogenous currents. All cells were included in analyses of current density. The liquid junction potential, series resistance and leak current for these recordings were not corrected, and cells were discarded if series resistance was >8 MΩ. The bath solution contained (in mM): NaCl 124, TEA-Cl 20, CaCl2 2.0, MgCl2 1, HEPES 5, glucose 10, pH 7.3 (adjusted with NaOH). The intracellular “0 Ca2+” solution contained (in mM): CsCl2 60, L-aspartic acid 80, 1,2-bis(o-amino phenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA) 10, HEPES 10, pH 7.35 (adjusted with CsOH). The intracellular “10 μM Ca2+” solution contained (in mM): CsCl2 60, L-aspartic acid 80, BAPTA 1, CaCl2 1, HEPES 10, pH 7.30 (adjusted with CsOH). Osmolarity was adjusted to 310 mOsm with sucrose for all solutions. The voltage-clamp protocols were generated by PatchMaster. Cells were voltage-clamped at a holding potential (Vh) of -120 mV, and currents were elicited by depolarizing pulses of 40 ms from -120 mV to +45 mV in 5 mV increments. Current density was calculated by normalizing to cell capacitance. Activation curves were obtained by transforming current data to conductance (G), which was calculated from the equation GNa = I/(V - Erev), where: I is the peak Na+ current elicited by the depolarizing test potential; V is the test potential; and Erev is the calculated Na+ reversal potential. The ratio G/Gmax was plotted against the membrane potential and fitted with the Boltzmann equation of the form: G / Gmax=(1+exp[(V-V1/2)/k])-1, where Gmax is the extrapolated maximum conductance, V is the test voltage, V1/2 is the half-activation voltage, and k is the slope factor. Standard two-pulse protocols were used to generate the steady-state inactivation curves: from a holding potential of -120 mV, cells were stepped to 500-ms preconditioning potentials varying between -130 mV and -10 mV (prepulse) in 5 mV increments, followed by a 20 ms test pulse to -20 mV. Currents (I) were normalized to Imax and fit to a Boltzmann function of the form I/Imax =1/(1+exp((Vm-V1/2)/k)) in which V1/2 is the voltage at which half of NaV1.5 channels are inactivated, k is the slope factor and Vm is the membrane potential. Data analysis was performed using FitMaster (HEKA Elektronik) and Origin 8 software. Results are presented as means ± standard error; the statistical significance of differences between groups was assessed using a two-tailed Student's t-test and was set at P< 0.05.
Supplementary Material
Acknowledgments
Data for this study were collected at beam lines NE-CAT ID 24-C and SER-CAT BM22/ID22 and at the Advanced Photon Source and the Duke X-ray Crystallography Facility. We thank R. Brennan, M. Schumacher, and P. Zhou for providing access to their ITC machines; C. Pemble for help with remote data collection. This work was supported by NHLBI R01 HL71165 and HL113136 (G.S.P.), and American Heart Association Established Investigator Award (G.S.P.); start-up funds from the Duke University Medical Center (S.-Y.L.), the Basil O'Connor Starter Scholar Research Award 5-FY10-473 from the March of Dimes foundation (S.-Y.L.), the N.I.H. Director's New Innovator Award 1 DP2 OD008380-01 (S.-Y.L). S.-Y.L. is a McKnight Scholar, Klingenstein fellow, Alfred P. Sloan Research fellow, Mallinckrodt Scholar, and Whitehead Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Footnotes
Author contributions: S-YL and GSP designed the study. CW, BCC, HY, and H-GG performed experiments. All authors analyzed data. S-YL and GSP wrote the manuscript.
Accession Numbers: Atomic coordinates and structure factors for the reported crystal structures have been deposited in the Protein Data Bank under accession codes 4JPZ and 4JQ0, for the NaV1.2/Ca2+ and NaV1.5/Ca2+ structures, respectively.
Competing financial interest: The authors declare no competing financial interests.
References
- 1.Payandeh J, Scheuer T, Zheng N, Catterall WA. The crystal structure of a voltage-gated sodium channel. Nature. 2011;475:353–358. doi: 10.1038/nature10238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Payandeh J, Gamal El-Din TM, Scheuer T, Zheng N, Catterall WA. Crystal structure of a voltage-gated sodium channel in two potentially inactivated states. Nature. 2012;486:135–139. doi: 10.1038/nature11077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mantegazza M, Yu FH, Catterall WA, Scheuer T. Role of the C-terminal domain in inactivation of brain and cardiac sodium channels. Proc Natl Acad Sci U S A. 2001;98:15348–15353. doi: 10.1073/pnas.211563298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Goldfarb M, et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron. 2007;55:449–463. doi: 10.1016/j.neuron.2007.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mori M, Konno T, Ozawa T, Murata M, Imoto K, Nagayama K. Novel interaction of the voltage-dependent sodium channel (VDSC) with calmodulin: does VDSC acquire calmodulin-mediated Ca2+-sensitivity? Biochemistry. 2000;39:1316–1323. doi: 10.1021/bi9912600. [DOI] [PubMed] [Google Scholar]
- 6.Catterall WA, Kalume F, Oakley JC. NaV1.1 channels and epilepsy. J Physiol. 2010;588:1849–1859. doi: 10.1113/jphysiol.2010.187484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Weiss LA, et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry. 2003;8:186–194. doi: 10.1038/sj.mp.4001241. [DOI] [PubMed] [Google Scholar]
- 8.Lossin C. A catalog of SCN1A variants. Brain & development. 2009;31:114–130. doi: 10.1016/j.braindev.2008.07.011. [DOI] [PubMed] [Google Scholar]
- 9.Wang Q, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–811. doi: 10.1016/0092-8674(95)90359-3. [DOI] [PubMed] [Google Scholar]
- 10.Bennett PB, Yazawa K, Makita N, George AL., Jr Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683–685. doi: 10.1038/376683a0. [DOI] [PubMed] [Google Scholar]
- 11.Antzelevitch C. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659–670. doi: 10.1161/01.CIR.0000152479.54298.51. [DOI] [PubMed] [Google Scholar]
- 12.Bannister RA, Melliti K, Adams BA. Differential modulation of CaV2.3 Ca2+ channels by Galphaq/11-coupled muscarinic receptors. Mol Pharmacol. 2004;65:381–388. doi: 10.1124/mol.65.2.381. [DOI] [PubMed] [Google Scholar]
- 13.Bezzina CR, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res. 2003;92:159–168. doi: 10.1161/01.res.0000052672.97759.36. [DOI] [PubMed] [Google Scholar]
- 14.Crotti L, et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009–1017. doi: 10.1161/CIRCULATIONAHA.112.001216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.van Swieten JC, et al. A Mutation in the Fibroblast Growth Factor 14 Gene Is Associated with Autosomal Dominant Cerebral Ataxia. The American Journal of Human Genetics. 2003;72:191–199. doi: 10.1086/345488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hennessey JA, et al. FGF12 is a candidate Brugada syndrome locus. Heart Rhythm. 2013;10:1886–1894. doi: 10.1016/j.hrthm.2013.09.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pitt GS. Calmodulin and CaMKII as molecular switches for cardiac ion channels. Cardiovasc Res. 2007;73:641–647. doi: 10.1016/j.cardiores.2006.10.019. [DOI] [PubMed] [Google Scholar]
- 18.Wingo TL, Shah VN, Anderson ME, Lybrand TP, Chazin WJ, Balser JR. An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol. 2004;11:219–225. doi: 10.1038/nsmb737. [DOI] [PubMed] [Google Scholar]
- 19.Herzog RI, Liu C, Waxman SG, Cummins TR. Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties. J Neurosci. 2003;23:8261–8270. doi: 10.1523/JNEUROSCI.23-23-08261.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tan HL, et al. A calcium sensor in the sodium channel modulates cardiac excitability. Nature. 2002;415:442–447. doi: 10.1038/415442a. [DOI] [PubMed] [Google Scholar]
- 21.Kim J, Ghosh S, Liu H, Tateyama M, Kass RS, Pitt GS. Calmodulin mediates Ca2+ sensitivity of sodium channels. J Biol Chem. 2004;279:45004–45012. doi: 10.1074/jbc.M407286200. [DOI] [PubMed] [Google Scholar]
- 22.Rusconi R, et al. A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies? Hum Mutat. 2009;30:E747–760. doi: 10.1002/humu.21041. [DOI] [PubMed] [Google Scholar]
- 23.Haug K, et al. The voltage-gated sodium channel gene SCN2A and idiopathic generalized epilepsy. Epilepsy Res. 2001;47:243–246. doi: 10.1016/s0920-1211(01)00312-6. [DOI] [PubMed] [Google Scholar]
- 24.Zucca C, et al. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified. Arch Neurol. 2008;65:489–494. doi: 10.1001/archneur.65.4.489. [DOI] [PubMed] [Google Scholar]
- 25.Sanders SJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485:237–241. doi: 10.1038/nature10945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.O'Roak BJ, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485:246–250. doi: 10.1038/nature10989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.O'Roak BJ, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585–589. doi: 10.1038/ng.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Feldkamp MD, Yu L, Shea MA. Structural and energetic determinants of apo calmodulin binding to the IQ motif of the Na(V)1.2 voltage-dependent sodium channel. Structure. 2011;19:733–747. doi: 10.1016/j.str.2011.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chagot B, Chazin WJ. Solution NMR structure of Apo-calmodulin in complex with the IQ motif of human cardiac sodium channel NaV1.5. J Mol Biol. 2011;406:106–119. doi: 10.1016/j.jmb.2010.11.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Wang C, Chung BC, Yan H, Lee SY, Pitt GS. Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin. Structure. 2012;20:1167–1176. doi: 10.1016/j.str.2012.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Laezza F, et al. The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci. 2007;27:12033–12044. doi: 10.1523/JNEUROSCI.2282-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wang C, et al. Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts. Circ Res. 2011;109:775–782. doi: 10.1161/CIRCRESAHA.111.247957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Miloushev VZ, Levine JA, Arbing MA, Hunt JF, Pitt GS, Palmer AG., 3rd Solution structure of the NaV1.2 C-terminal EF-hand domain. J Biol Chem. 2009;284:6446–6454. doi: 10.1074/jbc.M807401200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chagot B, Potet F, Balser JR, Chazin WJ. Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5. J Biol Chem. 2009;284:6436–6445. doi: 10.1074/jbc.M807747200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Goetz R, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem. 2009;284:17883–17896. doi: 10.1074/jbc.M109.001842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Houdusse A, Cohen C. Target sequence recognition by the calmodulin superfamily: implications from light chain binding to the regulatory domain of scallop myosin. Proc Natl Acad Sci U S A. 1995;92:10644–10647. doi: 10.1073/pnas.92.23.10644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Meador WE, Means AR, Quiocho FA. Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science. 1992;257:1251–1255. doi: 10.1126/science.1519061. [DOI] [PubMed] [Google Scholar]
- 38.Sarhan MF, Tung CC, Van Petegem F, Ahern CA. Crystallographic basis for calcium regulation of sodium channels. Proc Natl Acad Sci U S A. 2012;109:3558–3563. doi: 10.1073/pnas.1114748109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Willsey AJ, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155:997–1007. doi: 10.1016/j.cell.2013.10.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wang Q, et al. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron. 2002;35:25–38. doi: 10.1016/s0896-6273(02)00744-4. [DOI] [PubMed] [Google Scholar]
- 41.Wang C, Wang HG, Xie H, Pitt GS. Ca2+/CaM controls Ca2+-dependent inactivation of NMDA receptors by dimerizing the NR1 C termini. J Neurosci. 2008;28:1865–1870. doi: 10.1523/JNEUROSCI.5417-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Shah VN, Wingo TL, Weiss KL, Williams CK, Balser JR, Chazin WJ. Calcium-dependent regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a common molecular switch. Proc Natl Acad Sci U S A. 2006;103:3592–3597. doi: 10.1073/pnas.0507397103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cha A, Ruben PC, George AL, Fujimoto E, Bezanilla F. Voltage Sensors in Domains III and IV, but Not I and II, Are Immobilized by Na+ Channel Fast Inactivation. Neuron. 1999;22:73–87. doi: 10.1016/s0896-6273(00)80680-7. [DOI] [PubMed] [Google Scholar]
- 44.Capes DL, Goldschen-Ohm MP, Arcisio-Miranda M, Bezanilla F, Chanda B. Domain IV voltage-sensor movement is both sufficient and rate limiting for fast inactivation in sodium channels. J Gen Physiol. 2013;142:101–112. doi: 10.1085/jgp.201310998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Shakkottai VG, et al. FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis. 2009;33:81–88. doi: 10.1016/j.nbd.2008.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005;115:2010–2017. doi: 10.1172/JCI25466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ben-Johny M, Yang PS, Niu J, Yang W, Joshi-Mukherjee R, Yue DT. Conservation of Ca/Calmodulin Regulation across Na and Ca Channels. Cell. 2014;157:1657–1670. doi: 10.1016/j.cell.2014.04.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Potet F, et al. Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin. J Biol Chem. 2009;284:8846–8854. doi: 10.1074/jbc.M806871200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Sarhan MF, Van Petegem F, Ahern CA. A double tyrosine motif in the cardiac sodium channel domain III-IV linker couples calcium-dependent calmodulin binding to inactivation gating. J Biol Chem. 2009;284:33265–33274. doi: 10.1074/jbc.M109.052910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Yizhar O, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171–178. doi: 10.1038/nature10360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Schumacher MA, Rivard AF, Bachinger HP, Adelman JP. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature. 2001;410:1120–1124. doi: 10.1038/35074145. [DOI] [PubMed] [Google Scholar]
- 52.Erickson MG, Alseikhan BA, Peterson BZ, Yue DT. Preassociation of calmodulin with voltage-gated Ca(2+) channels revealed by FRET in single living cells. Neuron. 2001;31:973–985. doi: 10.1016/s0896-6273(01)00438-x. [DOI] [PubMed] [Google Scholar]
- 53.Tadross MR, Dick IE, Yue DT. Mechanism of local and global Ca2+ sensing by calmodulin in complex with a Ca2+ channel. Cell. 2008;133:1228–1240. doi: 10.1016/j.cell.2008.05.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.DeMaria CD, Soong TW, Alseikhan BA, Alvania RS, Yue DT. Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels. Nature. 2001;411:484–489. doi: 10.1038/35078091. [DOI] [PubMed] [Google Scholar]
- 55.de Leon M, et al. Essential Ca(2+)-binding motif for Ca(2+)-sensitive inactivation of L-type Ca2+ channels. Science. 1995;270:1502–1506. doi: 10.1126/science.270.5241.1502. [DOI] [PubMed] [Google Scholar]
- 56.Kim EY, et al. Multiple C-terminal tail Ca(2+)/CaMs regulate Ca(V)1.2 function but do not mediate channel dimerization. EMBO J. 2010;29:3924–3938. doi: 10.1038/emboj.2010.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Fallon JL, et al. Crystal structure of dimeric cardiac L-type calcium channel regulatory domains bridged by Ca2+* calmodulins. Proc Natl Acad Sci U S A. 2009;106:5135–5140. doi: 10.1073/pnas.0807487106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Holm L, Rosenstrom P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 2010;38:W545–549. doi: 10.1093/nar/gkq366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wang C, Wang C, Hoch EG, Pitt GS. Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels. J Biol Chem. 2011;286:24253–24263. doi: 10.1074/jbc.M111.245803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Yan H, Pablo JL, Pitt GS. FGF14 regulates presynaptic Ca2+ channels and synaptic transmission. Cell Rep. 2013;4:66–75. doi: 10.1016/j.celrep.2013.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta crystallographica Section D, Biological crystallography. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Strong M, Sawaya MR, Wang S, Phillips M, Cascio D, Eisenberg D. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:8060–8065. doi: 10.1073/pnas.0602606103. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.